Ambulatory Advanced Cancer Patients' and Oncologists' Estimates of Life Expectancy Are Associated with Patient Psychological Characteristics but Not Chemotherapy Use

Larry Cripe, Kevin L. Rand, Susan Perkins, Yan Tong, Karen Krall Schmidt, David G. Hedrick, Susan Rawl

Research output: Contribution to journalArticle

Abstract

Background: Patients with advanced cancer often face distressing decisions about chemotherapy. There are conflicting data on the relationships among perceived prognosis, psychological characteristics, and chemotherapy use, which impair the refinement of decision support interventions. Objective: Clarify the relationships among patient and oncologist estimates of life expectancy for 6 and 12 months, chemotherapy use, and patient psychological characteristics. Design: Secondary analysis of data from two cross-sectional studies. Setting/Subjects: One hundred sixty-six patients with advanced stage cancer recruited from ambulatory cancer clinics. Measurements: All data were obtained at study enrollment. Patients completed the Adult Hope Scale, Hospital Anxiety and Depression Scale, and Life Orientation Test-Revised. Patients and their oncologists provided estimates of surviving beyond 6 and 12 months. Chemotherapy use was determined by chart review. Results: There were no significant associations between life-expectancy estimates and chemotherapy use nor patient anxiety, depression, hope, or optimism and chemotherapy use. Patients' life expectancy estimates for 12 months and oncologists' for 6 months were associated with higher patient anxiety and depression. Finally, both oncologist and patient estimates of life expectancy for 6 and 12 months were associated with increased levels of trait hope. Conclusion: Advanced cancer patients who provide less optimistic estimates of life expectancy have increased anxiety and depression, but do not use chemotherapy more often. Increased patient trait hope is associated with more favorable oncologist estimates. These findings highlight the need for interventions to support both patients and oncologists as they clarify prognostic expectations and patients cope with the psychological distress of a limited life expectancy.

Original languageEnglish (US)
Pages (from-to)1107-1113
Number of pages7
JournalJournal of Palliative Medicine
Volume21
Issue number8
DOIs
StatePublished - Aug 1 2018

Fingerprint

Life Expectancy
Psychology
Drug Therapy
Hope
Neoplasms
Anxiety
Depression
Oncologists
Cross-Sectional Studies

Keywords

  • advanced cancer
  • chemotherapy
  • patient physician communication
  • prognostication

ASJC Scopus subject areas

  • Nursing(all)
  • Anesthesiology and Pain Medicine

Cite this

Ambulatory Advanced Cancer Patients' and Oncologists' Estimates of Life Expectancy Are Associated with Patient Psychological Characteristics but Not Chemotherapy Use. / Cripe, Larry; Rand, Kevin L.; Perkins, Susan; Tong, Yan; Schmidt, Karen Krall; Hedrick, David G.; Rawl, Susan.

In: Journal of Palliative Medicine, Vol. 21, No. 8, 01.08.2018, p. 1107-1113.

Research output: Contribution to journalArticle

@article{076829b40d564bf29968ae081c6f9878,
title = "Ambulatory Advanced Cancer Patients' and Oncologists' Estimates of Life Expectancy Are Associated with Patient Psychological Characteristics but Not Chemotherapy Use",
abstract = "Background: Patients with advanced cancer often face distressing decisions about chemotherapy. There are conflicting data on the relationships among perceived prognosis, psychological characteristics, and chemotherapy use, which impair the refinement of decision support interventions. Objective: Clarify the relationships among patient and oncologist estimates of life expectancy for 6 and 12 months, chemotherapy use, and patient psychological characteristics. Design: Secondary analysis of data from two cross-sectional studies. Setting/Subjects: One hundred sixty-six patients with advanced stage cancer recruited from ambulatory cancer clinics. Measurements: All data were obtained at study enrollment. Patients completed the Adult Hope Scale, Hospital Anxiety and Depression Scale, and Life Orientation Test-Revised. Patients and their oncologists provided estimates of surviving beyond 6 and 12 months. Chemotherapy use was determined by chart review. Results: There were no significant associations between life-expectancy estimates and chemotherapy use nor patient anxiety, depression, hope, or optimism and chemotherapy use. Patients' life expectancy estimates for 12 months and oncologists' for 6 months were associated with higher patient anxiety and depression. Finally, both oncologist and patient estimates of life expectancy for 6 and 12 months were associated with increased levels of trait hope. Conclusion: Advanced cancer patients who provide less optimistic estimates of life expectancy have increased anxiety and depression, but do not use chemotherapy more often. Increased patient trait hope is associated with more favorable oncologist estimates. These findings highlight the need for interventions to support both patients and oncologists as they clarify prognostic expectations and patients cope with the psychological distress of a limited life expectancy.",
keywords = "advanced cancer, chemotherapy, patient physician communication, prognostication",
author = "Larry Cripe and Rand, {Kevin L.} and Susan Perkins and Yan Tong and Schmidt, {Karen Krall} and Hedrick, {David G.} and Susan Rawl",
year = "2018",
month = "8",
day = "1",
doi = "10.1089/jpm.2017.0686",
language = "English (US)",
volume = "21",
pages = "1107--1113",
journal = "Journal of Palliative Medicine",
issn = "1096-6218",
publisher = "Mary Ann Liebert Inc.",
number = "8",

}

TY - JOUR

T1 - Ambulatory Advanced Cancer Patients' and Oncologists' Estimates of Life Expectancy Are Associated with Patient Psychological Characteristics but Not Chemotherapy Use

AU - Cripe, Larry

AU - Rand, Kevin L.

AU - Perkins, Susan

AU - Tong, Yan

AU - Schmidt, Karen Krall

AU - Hedrick, David G.

AU - Rawl, Susan

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Background: Patients with advanced cancer often face distressing decisions about chemotherapy. There are conflicting data on the relationships among perceived prognosis, psychological characteristics, and chemotherapy use, which impair the refinement of decision support interventions. Objective: Clarify the relationships among patient and oncologist estimates of life expectancy for 6 and 12 months, chemotherapy use, and patient psychological characteristics. Design: Secondary analysis of data from two cross-sectional studies. Setting/Subjects: One hundred sixty-six patients with advanced stage cancer recruited from ambulatory cancer clinics. Measurements: All data were obtained at study enrollment. Patients completed the Adult Hope Scale, Hospital Anxiety and Depression Scale, and Life Orientation Test-Revised. Patients and their oncologists provided estimates of surviving beyond 6 and 12 months. Chemotherapy use was determined by chart review. Results: There were no significant associations between life-expectancy estimates and chemotherapy use nor patient anxiety, depression, hope, or optimism and chemotherapy use. Patients' life expectancy estimates for 12 months and oncologists' for 6 months were associated with higher patient anxiety and depression. Finally, both oncologist and patient estimates of life expectancy for 6 and 12 months were associated with increased levels of trait hope. Conclusion: Advanced cancer patients who provide less optimistic estimates of life expectancy have increased anxiety and depression, but do not use chemotherapy more often. Increased patient trait hope is associated with more favorable oncologist estimates. These findings highlight the need for interventions to support both patients and oncologists as they clarify prognostic expectations and patients cope with the psychological distress of a limited life expectancy.

AB - Background: Patients with advanced cancer often face distressing decisions about chemotherapy. There are conflicting data on the relationships among perceived prognosis, psychological characteristics, and chemotherapy use, which impair the refinement of decision support interventions. Objective: Clarify the relationships among patient and oncologist estimates of life expectancy for 6 and 12 months, chemotherapy use, and patient psychological characteristics. Design: Secondary analysis of data from two cross-sectional studies. Setting/Subjects: One hundred sixty-six patients with advanced stage cancer recruited from ambulatory cancer clinics. Measurements: All data were obtained at study enrollment. Patients completed the Adult Hope Scale, Hospital Anxiety and Depression Scale, and Life Orientation Test-Revised. Patients and their oncologists provided estimates of surviving beyond 6 and 12 months. Chemotherapy use was determined by chart review. Results: There were no significant associations between life-expectancy estimates and chemotherapy use nor patient anxiety, depression, hope, or optimism and chemotherapy use. Patients' life expectancy estimates for 12 months and oncologists' for 6 months were associated with higher patient anxiety and depression. Finally, both oncologist and patient estimates of life expectancy for 6 and 12 months were associated with increased levels of trait hope. Conclusion: Advanced cancer patients who provide less optimistic estimates of life expectancy have increased anxiety and depression, but do not use chemotherapy more often. Increased patient trait hope is associated with more favorable oncologist estimates. These findings highlight the need for interventions to support both patients and oncologists as they clarify prognostic expectations and patients cope with the psychological distress of a limited life expectancy.

KW - advanced cancer

KW - chemotherapy

KW - patient physician communication

KW - prognostication

UR - http://www.scopus.com/inward/record.url?scp=85052311867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052311867&partnerID=8YFLogxK

U2 - 10.1089/jpm.2017.0686

DO - 10.1089/jpm.2017.0686

M3 - Article

AN - SCOPUS:85052311867

VL - 21

SP - 1107

EP - 1113

JO - Journal of Palliative Medicine

JF - Journal of Palliative Medicine

SN - 1096-6218

IS - 8

ER -